You are here

Synthesis & Characterization of a Tuberculosis Vaccine

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43AI056880-01A1
Agency Tracking Number: AI056880
Amount: $133,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Timeline
Solicitation Year: 2004
Award Year: 2004
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
ANCORA PHARMACEUTICALS 700 HURON AVE, #18K
CAMBRIDGE, MA 02138
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 OBADIH Plante
 (781) 395-7700
 OPLANTE@ANCORAPHARMA.COM
Business Contact
 JOHN PENA
Phone: (617) 354-0863
Email: JPENA@ANCORAPHARMA.COM
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): Tuberculosis (TB) has plagued mankind for millennia. While several drugs and vaccine strategies have been developed to counter the TB, it remains a major infectious cause of morbidity and mortality worldwide. 1.Thoug

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government